BioNexus Gene Lab
BGLC
#10254
Rank
โ‚ฌ4.12 M
Marketcap
0,23ย โ‚ฌ
Share price
-12.17%
Change (1 day)
-57.86%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2023 (TTM): -0,04240ย โ‚ฌ

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is -0,04127ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,02175ย โ‚ฌ a decrease over its 2021 EPS that were of 0,03294ย โ‚ฌ.

EPS history for BioNexus Gene Lab from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,04240ย โ‚ฌ94.95%
2022-0,02175ย โ‚ฌ-166.02%
20210,03294ย โ‚ฌ-74.82%
20200,13ย โ‚ฌ-600.17%
2019-0,02616ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,98ย โ‚ฌ 4,699.33%๐Ÿ‡บ๐Ÿ‡ธ USA